Next Article in Journal
CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression
Next Article in Special Issue
Special Issue “Targets, Tracers and Translation Novel Radiopharmaceuticals Boost Nuclear Medicine”
Previous Article in Journal
Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer
Previous Article in Special Issue
Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
Journals
Pharmaceuticals
Volume 12
Issue 2
10.3390/ph12020088
pharmaceuticals-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

Printed Edition

A printed edition of this Special Issue is available at MDPI Books....
share announcement thumb_up
...
textsms
...
Correction of Pharmaceuticals 2019, 12(1), 13.
Open AccessCorrection

Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13

by
Maximilian Klingler
,
Christine Rangger
,
Dominik Summer
,
Piriya Kaeopookum
,
Clemens Decristoforo
and
Elisabeth von Guggenberg
*
Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2019, 12(2), 88; https://doi.org/10.3390/ph12020088
Received: 11 June 2019 / Accepted: 12 June 2019 / Published: 13 June 2019
(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)
View Full-Text Download PDF
Browse Figure

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In our paper [...] View Full-Text
►▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
SciFeed

Share and Cite

MDPI and ACS Style

Klingler, M.; Rangger, C.; Summer, D.; Kaeopookum, P.; Decristoforo, C.; von Guggenberg, E. Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13. Pharmaceuticals 2019, 12, 88. https://doi.org/10.3390/ph12020088

AMA Style

Klingler M, Rangger C, Summer D, Kaeopookum P, Decristoforo C, von Guggenberg E. Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13. Pharmaceuticals. 2019; 12(2):88. https://doi.org/10.3390/ph12020088

Chicago/Turabian Style

Klingler, Maximilian; Rangger, Christine; Summer, Dominik; Kaeopookum, Piriya; Decristoforo, Clemens; von Guggenberg, Elisabeth. 2019. "Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13" Pharmaceuticals 12, no. 2: 88. https://doi.org/10.3390/ph12020088

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop